that's eric woodring. up next, the biggest movers into the close.ack right after this. >> the bond report is brought to >> the bond report is brought to you by pimco, a global it all started with a small business idea. it's a pillow with a speaker in it! that's right craig. pulling in the perfect team to get the job done. i'm just here for the internets. at&t, it's super-fast! you locked us out?! and when thrown a curveball... arrggghh! ahhhh! [crashing sounds] we had everything we needed. is the internet out? don't worry, we have at&t internet back-up. the next level network for small business. ♪♪ i sold a pillow! treatment for this disease. now, okiyo pharma is racing to become the first biotech ever with a drug to treat ncp. okiyo the first to initiate a phase two clinical trial for this disease. lead clinical site is tufts medical center. okiyo pharma's drug, if approved by the fda, would be the first ever for ncp. okiyo pharma symbol okiyo on the nasdaq. don't buy another stock before reading this book, because when you see the returns you coul

i spoke to a couple of analysts, including eric woodring, over at morgan stanley this week, who thinks that could put a 3% headwinds on earnings. and then, of course, like we said last week, kelly, the december quarter, china sales down 11%. a number of excuses from apple of why that was, but still a lot to be there. look just like what china's performance here on that chart. >> all right steve. thanks steve kovach john, obviously you're a shareholder at apple. how do you how do you think their position, what more do you need to hear. and is it a china issue for you or. i mean, they are supposed to be the big beneficiaries all of a sudden of this shift, right, where the people who are using the ai more so than the people who are just part of the investment cycle, are the beneficiaries, right? >> so, i mean, there's a lot, lot there. i think that that chart that was just up on the screen of, of apple revenues in china shows kind of what i'm focused on, which is apple's pressure in china has been a multiyear story. now, i think what what if we kind of rewind several years? apple initiall

i was emailing a bit back and forth the last few days with eric woodring over at morgan stanley. >> he predicts. >> about a 3% hit to earnings. >> if these. >> tariffs do go into full effect. >> and then. >> gene munster, our friend over at deep water management, he also noted on the manufacturing front, about half of apple sales are manufactured in china. that includes 85% of all iphones. india. we talked about that so much during the pandemic. with apple diverting some manufacturing over there to divert there to diversify their supply chain just 10%, according to gene of revenue is built in. >> india. >> though, so they. apple could still of course fight for exemptions, maybe offer trump something like an investment in the united states like they. did last time. trump, in fact, teased that apple would be announcing a major investment in the united states soon. but apple has not commented on that. and then, of course, we come to that inauguration moment a couple of weeks ago that. apparently wasn't enough. tim cook himself personally donated $1 million to the inauguration and sa